GridAI Technologies (GRDX) Preferred Shares (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Preferred Shares came in at $4.0 in Q2 2026, little changed quarter-over-quarter from $4.0 in Q4 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Preferred Shares (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Preferred Shares for 5 consecutive years, with $4.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Preferred Shares changed N/A year-over-year to $4.0; the trailing twelve-month figure through Jun 2026 stood at $4.0 (changed N/A YoY), and the FY2025 full-year result was $4.0, changed N/A from the prior year.
- Preferred Shares was little changed at $4.0 in Q2 2026 per GRDX's latest filing, from $4.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $10.0 million in Q3 2022 and bottomed at $4.0 in Q3 2025.
- Historically, Preferred Shares has averaged $2.5 million across 3 years, with a median of $4.0 in 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 4.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 |
| Dec 31, 2025 | 4.00 |
| Sep 30, 2025 | 4.00 |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2021 | 7,700.00 |
| Dec 31, 2015 | 3.48 Mn |